Capital Research Global Investors 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-09 12:32 pm Sale |
2023-06-12 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 0 0.000% |
-114,793,989 (Position Closed) |
Filing |
| 2023-02-13 3:32 pm Sale |
2023-02-14 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 114,793,989 10.300% |
-17,556,761 (-13.27%) |
Filing |
| 2022-02-11 12:22 pm Purchase |
2022-02-14 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 132,350,750 12.000% |
2,210,503 (+1.70%) |
Filing |
| 2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 130,140,247 11.900% |
130,140,247 (New Position) |
Filing |